We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Coin-Sized POC Device Detects Measles Virus in Saliva

By LabMedica International staff writers
Posted on 08 Jul 2022

Measles is one of the most infectious airborne viruses worldwide. With a basic reproduction rate of between 12-18, this virus is six times more infectious than the SARS-CoV-2 Alpha variant and similar to the SARS-CoV-2 Omicron variant. Even though a cheap and effective vaccine is available, measles is still common in developing countries. To date, sporadic outbreaks are also reported in developed countries, primarily due to non-vaccinated people. Now, a new point-of-care (POC) biosensing device that is capable of detecting measles virions (MV) in human saliva may help with efforts to control the viral spread.

The device developed by researchers at the Nanoscience Institute of the Italian National Research Council (Rome, Italy) is a surface-acoustic-wave (SAW) based lab-on-a-chip (LOC), smaller than a €1-cent coin, in which SAWs are used both for sensing and fluid recirculation. Experiments have validated the accuracy of the lab-on-a-chip device which may offer a convenient platform for measles diagnosis and serve as a guideline for designing new microfluidic biosensing systems.


Image: Novel POC biosensing device can detect measles virions in human saliva (Photo courtesy of Pexels)
Image: Novel POC biosensing device can detect measles virions in human saliva (Photo courtesy of Pexels)

“Our technology for the first time demonstrated the synergic operation of different surface-acoustic-wave-based micro devices on the same chip, in the context of lab-on-a-chip biosensing. In this way we have been able to drastically improve the detection limit of our sensors, potentially enabling early point-of-care diagnostic applications,” said senior author Marco Cecchini, PhD, Senior Researcher of the Nanoscience Institute of the Italian National Research Council.

Related Links:
Italian National Research Council


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Gold Member
Serum Indices Control
Acusera Serum Indices Control

Latest Technology News

Experimental Blood Test Detects Markers of Three Cancers and Alzheimer’s Disease
08 Jul 2022  |   Technology

New qPCR Master Mixes Offer Broad Compatibility for Routine Research
08 Jul 2022  |   Technology

Multi-Agent AI Framework Supports Laboratory Quality and Workflow Monitoring
08 Jul 2022  |   Technology